BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers
BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers
Recruiting · NCT06383013 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers | Diabetes Complications, Diabetic Foot, Foot Ulcer, Leg Ulcer, Skin Ulcer, Skin and Connective Tissue Diseases, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, skin disorder, vascular disorder | Recruiting | Phase 2 | 2026-10-02 | NCT06383013 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Blue Blood Biotech Corp. | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Linkou Chang Gung Memorial Hospital | Taoyuan | Taiwan | 7 |
| National Cheng Kung University Hospital | Tainan | Taiwan | 53 |
| Shin Kong Wu Ho-Su Memorial Hospital | Taipei | Taiwan | 8 |
| Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare | Taipei | Taiwan | 1 |
| Wanfang Hospital | Taipei | Taiwan | 3 |